Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EPS (Basic) (2018 - 2025)

Eton Pharmaceuticals' EPS (Basic) history spans 7 years, with the latest figure at $0.06 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 300.0% to $0.06 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.17, a 6.25% decrease, with the full-year FY2025 number at -$0.17, down 13.33% from a year prior.
  • EPS (Basic) hit $0.06 in Q4 2025 for Eton Pharmaceuticals, up from -$0.07 in the prior quarter.
  • Over the last five years, EPS (Basic) for ETON hit a ceiling of $0.21 in Q1 2021 and a floor of -$210.0 in Q1 2022.
  • Historically, EPS (Basic) has averaged -$10.53 across 5 years, with a median of -$0.06 in 2022.
  • Biggest five-year swings in EPS (Basic): plummeted 100100.0% in 2022 and later surged 400.0% in 2023.
  • Tracing ETON's EPS (Basic) over 5 years: stood at $0.04 in 2021, then rose by 0.0% to $0.04 in 2022, then crashed by 325.0% to -$0.09 in 2023, then surged by 66.67% to -$0.03 in 2024, then soared by 300.0% to $0.06 in 2025.
  • Business Quant data shows EPS (Basic) for ETON at $0.06 in Q4 2025, -$0.07 in Q3 2025, and -$0.1 in Q2 2025.